retatrutide ly3437943 triple agonist glp-1 gip glucagon mechanism Frontiers Triple Agonism Based Therapies for
Description
doi: 10.3760/cma.j.issn.0366-6999.2012.08.018 99 ZhuTWuXLZhangWXiaoM
[DOI] [PubMed] [Google Scholar] 363.Thorens B., Porret A., Buhler L., Deng S.P., Morel P., Widmann C
Bodnaruc, A
Structure/activity characterization of glucagon-like peptide-1
DPP-4, Dipeptidyl peptidase 4
